Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
---|
11/12/2009 | US20090281277 Peptides capable of binding to serum proteins and compounds, constructs and polypeptides comprising the same |
11/12/2009 | US20090281042 Compositions and methods using same for the detection of viruses |
11/12/2009 | US20090281041 Antiviral cell-penetrating peptides |
11/12/2009 | US20090281032 Modified CCK peptides |
11/12/2009 | US20090280190 Anti-angiogenic peptides from the n-terminus of endostatin |
11/12/2009 | US20090280165 Compounds that bind alpha5beta1 integrin and methods of use |
11/12/2009 | US20090280138 Peptide |
11/12/2009 | US20090280137 Methods, Compositions, and Sequences of ZP-Binding Peptides for Immunocontraception of Dogs and Other Animals |
11/12/2009 | US20090280125 Prion epitopes and methods of use thereof |
11/12/2009 | CA2723887A1 Peptide homing to brain tumors |
11/12/2009 | CA2721694A1 Biologically active peptides |
11/11/2009 | EP2116603A2 Antimicrobial peptides |
11/11/2009 | EP2116552A2 Peptides, derivatives thereof, process for producing the same, strain producing the same, and antiviral agent comprising the same as active ingredient |
11/11/2009 | EP2114988A2 Peptides and their use |
11/11/2009 | EP2114987A1 Foxp3 peptide vaccine |
11/11/2009 | EP2114986A1 Template-fixed peptidomimetics |
11/11/2009 | EP2114427A1 Peptides for treatment of conditions associated with nitric oxide |
11/11/2009 | EP1498421B1 Gamma-secretase inhibitors |
11/11/2009 | CN101578365A Vascular endothelial cell-binding peptide |
11/11/2009 | CN101575362A Cyclic pentapeptide human elastase inhibitor and preparation method thereof |
11/11/2009 | CN101575361A Novel specific polypeptide and application thereof in preparing medicament for diagnosing, preventing and treating severe acute respiratory syndrome caused by coronaviruses |
11/11/2009 | CN100558746C Kit for assaying human low-molecular weight CD14 and antibody |
11/11/2009 | CN100558743C Method for separating and purifying microcystin |
11/10/2009 | US7615615 Modified interferon beta with reduced immunogenicity |
11/10/2009 | US7615609 Preparation of somatostatin peptides |
11/10/2009 | US7615533 Peptide compounds derivatized with a hydrophilic polymer; solubility and circulation half-lives are increased and their immunogenicity is masked |
11/10/2009 | US7615359 Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use |
11/10/2009 | CA2335903C Novel cyclosporin with improved activity profile |
11/05/2009 | WO2009135118A2 Lyme disease vaccine |
11/05/2009 | WO2009134382A2 Cyclopeptides containing rgd mimetics as imaging markers for integrins |
11/05/2009 | WO2009134204A1 RESTORATION OF ESTROGEN RECEPTOR-α ACTIVITY |
11/05/2009 | WO2009133905A1 Peptide capable of inhibiting activity of human fibroblast growth factor-23 (human fgf-23), and pharmaceutical composition comprising the same |
11/05/2009 | WO2009133188A1 Pepstatin a derivatives |
11/05/2009 | WO2009132455A1 Protein splicing using short terminal split inteins |
11/05/2009 | WO2009132397A1 Methods and agents for modulating the level and/or activity of hif-2 alpha protein |
11/05/2009 | WO2009100513A3 Peptide des-[asp1]-[ala1], angi0tensin-(1 -7) agonist and pharmaceutical compounds for the treatment of diseases |
11/05/2009 | WO2009059011A3 Hla-dr binding peptides and their uses |
11/05/2009 | WO2009032693A9 Synthetic apolipoprotein e mimicking polypeptides and methods of use |
11/05/2009 | WO2008114976A8 Spinorphin derivatives as potent and selective human p2x3 receptor antagonist |
11/05/2009 | WO2007112345A8 Use of cyclosporin alkene analogues for preventing or treating viral-induced disorders |
11/05/2009 | US20090276160 using the crystal structures and structural coordinates to identify homologous proteins and to design or identify agents that can modulate the function of the HGFA |
11/05/2009 | US20090275730 Temperature responsive depsipeptide polymer |
11/05/2009 | US20090275727 Peptide turn mimetics |
11/05/2009 | US20090275664 Novel polyamine analog conjugates and quinone conjugates as therapies for cancers and prostate diseases |
11/05/2009 | US20090275522 Novel Compounds |
11/05/2009 | US20090275506 Long lasting natriuretic peptide derivatives |
11/05/2009 | US20090275504 Pcsk9 proteins, fragments thereof and methods of modulating pcsk9 phosphorylation and low density lipoprotein (ldlr) degradation |
11/05/2009 | US20090275503 Diastereomeric peptides for modulating t cell immunity |
11/05/2009 | US20090275501 Somatostatin-dopamine chimeric analogs |
11/05/2009 | US20090275500 Peptide-containing food intake regulator |
11/05/2009 | US20090275498 Novel peptides |
11/05/2009 | US20090275101 polynucleotides and polypeptides which are under-expressed in cancer and dysplasia delivered therapeutically to reduce the abnormal characteristics of cancer and dysplastic cells |
11/05/2009 | US20090275083 Isolated peptides having phospholipase inhibitory activity |
11/05/2009 | US20090275020 Traceability of Cellular Cycle Anomalies Targeting Oncology and Neurodegeneration |
11/05/2009 | US20090274714 Tumour-associated peptides binding to human leukocyte antigen (hla) class i or ii molecules and related anti-cancer vaccine |
11/05/2009 | US20090274658 Tight Junction Modulating Peptides for Enhanced Mucosal Delivery of Therapeutic Compounds |
11/05/2009 | US20090274625 Compositions and Methods for The Treatment of Cancer |
11/05/2009 | US20090274619 Tumor vasculature markers and methods of use therof |
11/05/2009 | CA2725601A1 Supercharged proteins for cell penetration |
11/05/2009 | CA2722854A1 Restoration of estrogen receptor-.alpha. activity |
11/04/2009 | EP2113510A1 Pepstatin A derivatives |
11/04/2009 | EP1559721B1 Fprl1 ligands and use thereof |
11/04/2009 | EP1542716B1 Growth hormone releasing peptides |
11/04/2009 | EP1375664B1 Method for the secretion and production of protein |
11/03/2009 | US7612166 Fluorous capping reagents and methods for peptide purification |
11/03/2009 | US7612037 Vancomycin coupled through an oxime to and aminochlorothiazolo pyridinium substituted bicyclic hetero ring; antibiotics |
11/03/2009 | US7611907 Nano-sized optical fluorescence labels and uses thereof |
11/03/2009 | US7611865 Genetic engineering |
11/03/2009 | US7611724 Produced from Chromobacterium cultures; depsipeptides; immunosuppressants; for treatment of graft-versus-host disease |
11/03/2009 | US7611711 VEGFR-3 inhibitor materials and methods |
11/03/2009 | CA2181548C Zinc finger protein derivatives and methods therefor |
10/29/2009 | WO2009131395A2 Angiogenic peptide |
10/29/2009 | WO2009131191A1 Metastin derivative and use thereof |
10/29/2009 | WO2009130612A2 Prion epitopes and methods of use thereof |
10/29/2009 | WO2009102909A3 Anti-cancer vaccines |
10/29/2009 | US20090270334 Neuronal differentiation inhibitor peptide and use thereof |
10/29/2009 | US20090270333 Methods of using motilin homologs |
10/29/2009 | US20090270312 Hiv-i gp41 fusion peptides for immunomodulaltion |
10/29/2009 | US20090269847 Self-assembling peptide amphiphiles and related methods for growth factor delivery |
10/29/2009 | US20090269739 Kit for detection of telomerase reverse transcriptase nucleic acids |
10/29/2009 | US20090269370 Vaccines comprising multimeric hsp60 peptide carriers |
10/29/2009 | US20090269366 T cell epitope peptides of 6b11 ovarian cancer anti-idiotypic antibody |
10/29/2009 | US20090269285 Diagnostic And Therapeutic Epitope, And Transgenic Plant |
10/29/2009 | DE10154458B4 Peptide zur Analyse von Gluten in Lebensmitteln und anderen Substanzgemischen und deren Verwendung Peptides for analysis of gluten in foodstuffs and other mixtures of substances and their use |
10/29/2009 | CA2727973A1 Peptidyl diacylglycerides |
10/29/2009 | CA2721833A1 Prion epitopes and methods of use thereof |
10/28/2009 | EP2112159A2 Immuno-interactive fragments of the alpha C subunit of inhibin |
10/28/2009 | EP2111410A2 Peptide inhibitors of metallo- ectopeptidases, compositions comprising said compounds and their pharmaceutical and cosmetic uses |
10/28/2009 | EP2111237A2 Fibrin-binding peptides and conjugates thereof |
10/28/2009 | EP2111227A1 Macrocyclic hepatitis c protease inhibitors |
10/28/2009 | EP2111220A2 Peptides that target to tumor blood vessels of lung cancer and applications thereof |
10/28/2009 | EP2111219A2 Lung cancer-targeted peptides and applications thereof |
10/28/2009 | EP1761631B1 Use of mycobacterial mannosylated lipoglycans peptide mimotopes for treating inflammation |
10/28/2009 | EP1474120B1 Antibody having a t-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer, viral infection and autoimmune disease |
10/28/2009 | CN101568550A Peptide vaccines for cancers expressing MPHOSPH1 or DEPDC1 polypeptides |
10/28/2009 | CN101565858A Composition containing peptide binding domain and method for forming nanoparticles and nanowires therefrom |
10/28/2009 | CN101565456A Combining epitope of mouse FcgammaRIII linear ligands |
10/28/2009 | CN101565455A CTL epitope polypeptides of bird flu H5N1 virus and applications thereof |
10/28/2009 | CN101565454A Mimic epitope peptide of mycobacterium tuberculosis MPT64 antigen and the application thereof |
10/28/2009 | CN101565453A Nitrone compound capable of capturing free radicals, preparation method thereof and use thereof |